Feasibility of Outpatient High Dose Cytarabine in Patients with Acute Myeloid Leukemia

被引：1
|
作者：
Ng, Chin-Hin [1 ]
Chen, Xiaojuan [1 ]
Lee, Foong-Gwan [1 ]
Choong, Shi Hui Clarice [1 ]
Saw, Xiao-Shi [2 ]
Sai, Lon-Wann [1 ]
Poon, Michelle [1 ]
Chan, Hian Li Esther Hian Li [1 ]
Ooi, Melissa [1 ]
Chee, Yen Lin [1 ]
Lee, Yee Mei [1 ]
机构：
[1] Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore
[2] Natl Univ Singapore Hosp, Dept Pharm, Singapore, Singapore
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and feasibility of outpatient high-dose cytarabine and intermediate-dose cytarabine for consolidation therapy in acute myeloid leukemia
    Li, Wenhui
    Richter, Katherine
    Lee, Jamie
    McCarthy, Kevin
    Kubal, Timothy
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1812 - 1818
  • [2] Safety and feasibility of outpatient high-dose cytarabine (HIDAC) and intermediate-dose cytarabine (IDAC) for consolidation therapy in acute myeloid leukemia (AML).
    Li, Wenhui
    Simondsen, Katherine
    Lee, Jamie
    Elharake, Maher
    Kubal, Timothy Edward
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Safety, Feasibility, and Cost-Effectiveness with Outpatient Administration of High-Dose Cytarabine Consolidation in Acute Myeloid Leukemia
    Wetzstein, Gene A.
    Lancet, Jeffrey E.
    Kallner, Jennifer E.
    Sivik, Jeffrey M.
    Ho, Viet Q.
    George, Timothy J.
    Desai, Sheetal
    Fisher, Shanel
    Newton, Michael D.
    List, Alan F.
    BLOOD, 2008, 112 (11) : 838 - 839
  • [4] Cytarabine Dose for Acute Myeloid Leukemia
    Lowenberg, Bob
    Pabst, Thomas
    Vellenga, Edo
    van Putten, Wim
    Schouten, Harry C.
    Graux, Carlos
    Ferrant, Augustin
    Sonneveld, Pieter
    Biemond, Bart J.
    Gratwohl, Alois
    de Greef, Georgine E.
    Verdonck, Leo F.
    Schaafsma, Martijn R.
    Gregor, Michael
    Theobald, Matthias
    Schanz, Urs
    Maertens, Johan
    Ossenkoppele, Gert J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (11): : 1027 - 1036
  • [5] Cytarabine Dose for Acute Myeloid Leukemia
    Mori, Jinichi
    Tsubokura, Masaharu
    Kami, Masahiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2166 - 2167
  • [6] High dose cytarabine or transplantation for consolidation of younger patients with acute myeloid leukemia
    Burnett, AK
    Kell, J
    CURRENT OPINION IN ONCOLOGY, 2000, 12 (02) : 110 - 115
  • [7] Implementation of a High-Dose Cytarabine Outpatient Program for Acute Myeloid Leukemia Patients in a Limited-Source Setting
    Haro, Juan C.
    Espinoza-Morales, Evelyn
    Espino, Johan
    Jimenez-Mozo, Fatima
    Poma, Nathaly
    Casas, Jhoisy
    Castro-Mollo, Melanie
    Sandival, Gustavo
    Ortega, Emperatriz
    Roque, Katia
    Lopez, Lourdes
    Alcarraz, Cindy
    Lozano, Sophia
    Cervantes, Elizabeth
    Quintana, Shirley
    Vidaurre, Tatiana
    Enriquez, Daniel J.
    BLOOD, 2021, 138
  • [8] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    BLOOD, 1996, 88 (02) : 754 - 754
  • [9] High-dose cytarabine benefits patients with acute myeloid leukemia and RAS mutations
    不详
    Nature Clinical Practice Oncology, 2009, 6 (1): : 3 - 4
  • [10] Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia
    Ochs, Madeleine A.
    Perissinotti, Anthony J.
    Marini, Bernard L.
    Burke, Patrick W.
    Bixby, Dale L.
    Pettit, Kristen M.
    Benitez, Lydia L.
    LEUKEMIA RESEARCH, 2021, 102
12345